ASTROTECH Corp Deferred Revenue
ASTROTECH Corp (ASTC) had Deferred Revenue of $0 as of 2017-06-30, per its 10-K filed 2017-09-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-09-18
- 2017-06-30: Deferred Revenue, Current $0.00.
- 2016-06-30: Deferred Revenue, Current $54.00K.
- 2015-06-30: Deferred Revenue, Current $60.00K.
- 2014-06-30: Deferred Revenue, Current $872.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-06-30 | $0.00 10-K · filed 2017-09-18 |
| 2016-06-30 | $54.00K 10-K · filed 2017-09-18 |
| 2015-06-30 | $60.00K 10-K · filed 2016-09-29 |
| 2014-06-30 | $872.00K 10-K · filed 2014-09-30 |
| 2014-03-31 | $3.20M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.34M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $1.59M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.30M 10-K · filed 2014-09-30 |
| 2013-03-31 | $3.01M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.06M 10-Q · filed 2013-02-14 |
| 2012-09-30 | $2.92M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $2.84M 10-K · filed 2013-10-15 |
| 2012-03-31 | $6.53M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $12.36M 10-Q · filed 2012-02-03 |
| 2011-09-30 | $11.04M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $10.92M 10-K · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |